FDA’s Dr. Marta Sokolowska provides closing remarks as we come to the end of the public session of the Online Controlled Substances Summit.
Reagan-Udall Foundation for the FDA’s Post
More Relevant Posts
-
In a new issue brief, Randall Lutter discusses why the current drug shortage crisis is even worse than it appears and what actions Congress should take to effectively respond. Read the entire issue brief here: https://bit.ly/3RvOv32
To view or add a comment, sign in
-
The theme for World Drug Day 2024 is “The evidence is clear: Invest in prevention”.
To view or add a comment, sign in
-
Are you wondering what ZaZa is? So was I when I had to treat a patient that had dependence, toxicity and eventually death from it. Now, I have a second patient!!! They are unsuspecting victims, under the impression they are just taking supplements bought across the counter at your nearest gas station, smoke shop or convenience store. It contains Tianeptine, a tricyclic Antidepressant that is not FDA approved. Nine states in the United States are already ahead of the game and banned it! I presented a poster at the recent National American College of Physicians scientific meeting. See below. Clinicians need to have a high index of suspicion, Users need to be educated on the risks! We need more data to understand the implications of its unregulated use.
To view or add a comment, sign in
-
Join us on Monday, April 22, for a live webinar: Application of Quality Standards in Substance Use Prevention and Treatment: Findings and Ways Forward based on the FENIQS-EU Project. This webinar will go over case study reports on good practice examples of enhanced implementation of Quality Standards in drug prevention, treatment and harm reduction throughout Europe. Register here: https://lnkd.in/epHUNJGp #ICUDDRWEBINAR #ICUDDR
To view or add a comment, sign in
-
USFDA NDSRI Limits update -Mar 2024 N-nitroso-varenicline is deleted from table 2 and added in table 1. Now the AI is 400 ng/day while previously it was 37 ng/day. Indeed a good news to industry. Background:- At first, the FDA decided the interim limit of varenicline as 185ng/day aside from 37ng/day. Then the interim limit was lifted because US manufacturers could adequately supply the market with varenicline at or below the acceptable intake limit of 37 ng per day. The 400ng/day is from CPCA and is the same as the limit by EMA. It looks more appropriate than read-across from NTHP(37ng/day). The MDD of Chantix is 2mg. The range of test methods that the FDA recommended is 1-200 ppm. It covers 400ng/day. https://www.fda.gov
To view or add a comment, sign in
-
Do you anticipate the Food and Drug Administration’s (FDA) laboratory-developed test final rule creating unnecessary burdens for pathologists or negatively impacting patients’ lives, innovation, or the economy on your community? Your story could be used to help legislators understand how the oversight of tests should be based on protecting patients and providing access to safe diagnostic tests with a framework that is the least burdensome for laboratories. Click on the link below, fill out the form, and tell us more. https://brnw.ch/21wL5mi
To view or add a comment, sign in
-
Discover the crucial factors contributing to drug abuse and its impact on society. Gain insightful perspectives on addressing this prevalent issue in our latest blog post. Access the full article here: https://ift.tt/DqVz0Cc
To view or add a comment, sign in
-
Managing alcohol and other drug issues in elite sports is complex and requires a comprehensive health approach that goes beyond drug testing. Join our experts at our upcoming webinar to learn more about unique issues of alcohol and other drug policy in elite sports 👉 bit.ly/4dKIicC
To view or add a comment, sign in
-
🚨 NEW POLICY BLOG 🚨: "What You Need to Know About the Alliance for Hippocratic Medicine v. FDA Supreme Court Case" Get all the facts of the case and the summary of today's arguments here: https://bit.ly/3PFzhbH
To view or add a comment, sign in
-
What would you do if you found colored spots on your medicine? You might think it’s harmless, but it could be a sign of something serious. Discoloration can indicate degradation or contamination, which can pose risks to patient health. That’s why our experts in our Swiss GMP laboratory regularly investigate drug discoloration and find out the root cause. In one case we investigated, the source was a potentially harmful impurity that came from a specific excipient. Our investigation helped our client avoid future incidents by making informed decisions about the supply and quality of the excipient. This helped to protect patients and ensure the quality and safety of the medicine. For a safer future, learn how we can help you: https://lnkd.in/d6XE8snp #YoullBeAmazed #ProudToBeIntertk #DrugDevelopment #medicine
To view or add a comment, sign in
4,742 followers